Skip to main
Clinic Semaglutide

A generative reading of the semaglutide evidence base — GLP-1 receptor pharmacology, the STEP and SELECT trials, and what the literature actually measured.

Semaglutide Mechanism of Action: The GLP-1 Link

What GLP-1 lets Semaglutide change after a meal

How does semaglutide work? It acts like GLP-1, a hormone released after food. GLP-1 touches set places on cells. Those cells are in the pancreas, gut, brain, and heart. The pancreas then releases insulin when blood sugar rises. Another hormone that raises sugar falls. The stomach slows, and the brain senses fullness.

The body's GLP-1 lasts about 2 minutes. The body breaks it apart, and the kidneys clear the pieces. Semaglutide was made to last longer. A change at part 8 slows breakdown. A fat piece helps it hold albumin, a blood protein. That hold slows loss through the kidneys. The GLP-1 drug remains after 4 hours and after 4 days.

Semaglutide has about a 168-hour stay, not 2 minutes. That's a 5,000-fold rise [13]. It still matches the human GLP-1 hormone by about 94%. The Semaglutide page about its GLP-1 action gives the plain link. For you, the longer stay is the main change.

What makes Semaglutide act like GLP-1

Semaglutide closely copies the body's GLP-1 hormone. It matches about ~94% of that hormone. Three changes make the drug last. They sit at parts 8, 34, and 26 of its protein chain. One change adds a fat piece. Together, the changes stretch its stay from ~2 minutes to about 168 hours [13].

GLP-1 touches a set place on a cell. Semaglutide fits that same GLP-1 place. The fit starts a message inside the cell. In the pancreas, the message helps release insulin when sugar rises. In the brain, it cuts hunger. In the gut, it slows the stomach.

The drug holds tightly to that place on the cell. A small amount can start the message. STEP found larger effects at larger doses. You don't need the lab codes to follow what happened to people.

What makes Semaglutide act like GLP-1

What Semaglutide does in three body areas

Three body areas explain most study findings.

1. Pancreas and blood sugar: GLP-1 tells certain pancreas cells to release insulin. They do so when blood sugar rises. Low sugar is less likely than with sulfonylureas. Those pills force more insulin out. The GLP-1 drug also lowers a hormone that raises sugar. Sugar then rises less after a meal. Tests in cells suggest the pancreas cells may last longer [18].

2. Brain and hunger: One brain area helps set hunger. Semaglutide makes the cells that curb hunger more active. It quiets the cells that drive hunger [11]. In mice, this GLP-1 change peaked 12–24 hours after a shot [11]. That's animal work, not proof about timing in people. In human studies, people ate 24% less on average.

3. Gut and fullness: The GLP-1 drug slows the stomach muscles. Food stays there longer, so fullness lasts. The same change can cause nausea. It can also slow the bowel as doses rise.

For you, the main links are sugar, hunger, and fullness.

What later cell tests may help explain

A 2024 review found 4 kinds of change in cells kept in dishes [18]. All 4 are lab clues, not gains proved in people.

Blood sugar: Muscle and fat cells moved more sugar in from the blood. The drug helped sugar pass through the cell's outer wall. That may help explain better blood sugar after meals.

Belly fat: Cell tests found changes in how fat burns fuel. SELECT and STEP found more loss around the waist. The cell work may help explain that result. It doesn't prove the cause.

Blood vessels: Semaglutide lowered signs of swelling in cell tests. That may help explain less heart harm in SELECT [18]. Weight loss may not explain all of the heart change.

Long stay: A fat chain joins the drug at part 26. A link with two small units and part eight joins the pieces. The chain holds albumin in blood. The kidneys don't clear albumin fast. This GLP-1 drug is also shielded from breakdown. The hold keeps blood levels up all week [13].

The firm findings came from people. These cell tests only offer possible reasons.

What later cell tests may help explain

What the GLP-1 drug Semaglutide keeps doing after GLP-1 fades

The body's GLP-1 rises after a person eats. Gut cells release the GLP-1 hormone. A large nerve called the vagus carries part of its message. The hormone has a 2-minute span in blood. It is a brief meal signal.

Semaglutide acts like a longer copy of GLP-1. Its half-life is a 168-hour stretch. That means the drug can keep working across the week. It doesn't rise and fade with each meal. STEP and SUSTAIN found lasting changes in weight and sugar [13]. The body's own GLP-1 can't give that same week-long effect.

Brain areas that curb hunger get the longer message too. That may explain why people ate less in studies. The drug acts at the same places but stays much longer.